Literature DB >> 11872184

Triptans: do they differ?

Reijo Salonen1, Andrew Scott.   

Abstract

Headache care specialists agree that the introduction of sumatriptan constitutes a major advance in headache therapy, but they differ about whether other triptans offer clinically significant advantages over sumatriptan. This article examines this issue by considering the similarities and differences among triptans.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11872184     DOI: 10.1007/s11916-002-0009-6

Source DB:  PubMed          Journal:  Curr Pain Headache Rep        ISSN: 1534-3081


  41 in total

Review 1.  Triptans are all different.

Authors:  A M Rapoport; S J Tepper
Journal:  Arch Neurol       Date:  2001-09

Review 2.  What matters is not the differences between triptans, but the differences between patients.

Authors:  J R Saper
Journal:  Arch Neurol       Date:  2001-09

3.  Sumatriptan nasal spray in the acute treatment of migraine: a review of clinical studies.

Authors:  C Dahlöf
Journal:  Cephalalgia       Date:  1999-11       Impact factor: 6.292

Review 4.  Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy.

Authors:  P Tfelt-Hansen; P De Vries; P R Saxena
Journal:  Drugs       Date:  2000-12       Impact factor: 9.546

5.  Monitoring pregnancy outcomes after prenatal drug exposure through prospective pregnancy registries: a pharmaceutical company commitment.

Authors:  R Reiff-Eldridge; C R Heffner; S A Ephross; P S Tennis; A D White; E B Andrews
Journal:  Am J Obstet Gynecol       Date:  2000-01       Impact factor: 8.661

6.  Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials.

Authors:  M D Ferrari; K I Roon; R B Lipton; P J Goadsby
Journal:  Lancet       Date:  2001-11-17       Impact factor: 79.321

7.  Rizatriptan vs sumatriptan in the acute treatment of migraine. A placebo-controlled, dose-ranging study. Dutch/US Rizatriptan Study Group.

Authors:  W H Visser; G M Terwindt; S A Reines; K Jiang; C R Lines; M D Ferrari
Journal:  Arch Neurol       Date:  1996-11

8.  Crossover comparison of rizatriptan 5 mg and 10 mg versus sumatriptan 25 mg and 50 mg in migraine. Rizatriptan Protocol 046 Study Group.

Authors:  J Goldstein; R Ryan; K Jiang; A Getson; B Norman; G A Block; C Lines
Journal:  Headache       Date:  1998 Nov-Dec       Impact factor: 5.887

Review 9.  5-HT(1)-like receptor agonists and the pathophysiology of migraine.

Authors:  P R Saxena; M D Ferrari
Journal:  Trends Pharmacol Sci       Date:  1989-05       Impact factor: 14.819

10.  The clinical pharmacology, pharmacokinetics and metabolism of sumatriptan.

Authors:  P A Fowler; L F Lacey; M Thomas; O N Keene; R J Tanner; N S Baber
Journal:  Eur Neurol       Date:  1991       Impact factor: 1.710

View more
  1 in total

Review 1.  Newer formulations of the triptans: advances in migraine management.

Authors:  Jonathan Paul Gladstone; Marek Gawel
Journal:  Drugs       Date:  2003       Impact factor: 9.546

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.